SARS: Political Pathology of the First Post‐Westphalian Pathogen

David P Fidler

doi:10.1111/j.1748-720X.2003.tb00117.x

. 2007 Jan 24;31(4):485–505. doi: 10.1111/j.1748-720X.2003.tb00117.x

SARS: Political Pathology of the First Post‐Westphalian Pathogen

David P Fidler ¹

PMCID: PMC7166417 PMID: 14968652

The content is available as a PDF (2.3 MB).

References

1. See, e.g., Hunt P., The Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health: Report of the Special Rapporteur, UN Doc. E/CN.4/2003/58, February 13, 2003.
2. See, e.g., Commission on Macroeconomics and Health , Macroeconomics and Health: Investing in Health for Economic Development ( Geneva : World Health Organization, 2001). [Google Scholar]
3. See, e.g. Brower and Chalk P., The Global Threat of New and Reemerging Infectious Diseases: Reconciling U.S. National Security and Public Health Policy ( Santa Monica : RAND, 2003). [Google Scholar]
4. World Health Assembly , Severe Acute Respiratory Syndrome (SARS), WHA56.29, May 28, 2003.
5. See, e.g., Smolinski M. S., Hamburg M. A., and Lederberg J., eds., Microbial Threats to Health: Emergence, Detection, and Response ( Washington , D.C. : National Academy Press, 2003); World Health Organization, World Health Report 1996: Fighting Disease, Fostering Development (Geneva: World Health Organization, 1996); J. Lederberg, R. E. Shope, S. C. Oaks, eds., Emerging Infections: Microbial Threats to Health in the United States (Washington, D.C.: National Academy Press, 1992). [Google Scholar]
6. For an overview of the HIV/AIDS pandemic, see UNAIDS , AIDS Epidemic Update: December 2002 ( Geneva : UNAIDS, 2002). [Google Scholar]
7. See Gostin L. O., Public Health Law: Power, Duty, Restraint ( Berkeley : University of California Press, 2000): 25–59. [Google Scholar]
8. World Health Organization , Severe Acute Respiratory Syndrome (SARS): Status of the Outbreak and Lessons for the Immediate Future ( Geneva : World Health Organization, 2003): 3. [Google Scholar]
9. World Health Organization , Severe Acute Respiratory Syndrome (SARS) — Multi‐Country Outbreak (March 15, 2003), at <http://www.who.int/csr/don/2003_03_15/en/html> (last visited June 10, 2003).
10. Harding C. and Lim C.L., “The Significance of Westphalia: An Archaeology of the International Legal Order,” in Harding C. and Lim C.L., eds., Renegotiating Westphalia: Essays and Commentary on the European and Conceptual Foundations of Modern International Law ( The Hague : M. Nijhoff Publishers, 1999): 1–23. [Google Scholar]
11. Id. at 5–6.
12. Scholte J. A., “The Globalization of World Politics,” in Baylis J. and Smith S., eds., The Globalization of World Politics: An Introduction to International Relations, 2d ed. ( Oxford : Oxford University Press, 2001): 12–32, at 20. [Google Scholar]
13. Dunne T. and Schmidt B.C., “Realism,” in Baylis J. and Smith S., eds., The Globalization of World Politics: An Introduction to International Relations, 2d ed. ( Oxford : Oxford University Press, 2001):141–61, at 143. [Google Scholar]
14. Scholte, supra note 12, at 20; I. Brownlie, Principles of Public International Law, 5^th ed. (Oxford: Oxford University Press, 1998): at 289.
15. Jackson R.H., “The Evolution of International Society,” in Baylis J. and Smith S., eds., The Globalization of World Politics: An Introduction to International Relations, 2d ed. ( Oxford : Oxford University Press, 2001): 35–50: at 43; Brownlie, supra note 14, at 289, 293–94. [Google Scholar]
16. Brownlie, supra note 14, at 289; The S. S. Lotus (France v. Turkey), P. C. I. J. Series A, No. 10 (1927).
17. Bull H., The Anarchical Society: A Study of Order in World Politics ( Basingstoke : Macmillan, 1977): at 200–29. [Google Scholar]
18. Id. at 101–26; 184–99.
19. Fidler D.P., “The Return of the Standard of Civilization,” Chicago Journal of International Law, 2 (2001): 137–57; G. Gong, The “Standard of Civilization” in International Society (Oxford: Oxford University Press, 1984). [Google Scholar]
20. On this history, see Fidler D. P., International Law and Infectious Diseases ( Oxford : Clarendon Press, 1999): at 21–57; N. Howard‐Jones, The Scientific Background of the International Sanitary Conferences 1851–1938 (Geneva: World Health Organization, 1975) [hereinafter Howard‐Jones, Scientific Background]; N. M. Goodman, International Health Organizations and Their Work, 2d ed. (London: Churchill Livingstone, 1971); N. Howard‐Jones, “The Origins of International Health Work,”British Medical Journal, May 6, 1950: 1032–37 [hereinafter Howard‐Jones, “International Health Work”]. [Google Scholar]
21. This situation prompted Robert Koch to argue in 1894 that the negotiation of the international sanitary conventions on cholera was “quite superfluous” because what was needed was for every country “to seize cholera by the throat and stamp it out.” Howard‐Jones, Scientific Background, supra note 20, at 76 (quoting Robert Koch).
22. Fidler, supra note 20, at 35.
23. Id. at 28–35.
24. Howard‐Jones, “International Health Work,” supra note 20, at 1035.
25. World Health Organization , International Health Regulations, 3d. ann. ed. ( Geneva : World Health Organization, 1983) [hereinafter IHR]. [Google Scholar]
26. World Health Organization , Global Crises — Global Solutions: Managing Public Health Emergencies of International Concern Through the Revised International Health Regulations ( Geneva : World Health Organization, 2002): at 1. [Google Scholar]
27. Fidler D.P., “Emerging Trends in International Law Concerning Global Infectious Disease Control,” Emerging Infectious Diseases, 9 (2003): 285–90, at 285–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
28. IHR, supra note 25.
29. Id. at Articles 2–13.
30. Id. at Articles 14–22.
31. Id. at Article 23.
32. Id. at Article 1.
33. The first International Sanitary Conference in 1851 addressed maritime quarantine measures against plague, cholera, and yellow fever. Goodman, supra note 20, at 46.
34. On such widespread violations, see Fidler, supra note 20, at 65–66.
35. Delon P.J., The International Health Regulations: A Practical Guide ( Geneva : World Health Organization, 1975); E. Roelsgaard, “Health Regulations and International Travel,”Chronicle of the World Health Organization 28 (1974): 265–68; P. Dorolle, “Old Plagues in the Jet Age: International Aspects of Present and Future Control of Communicable Diseases,”Chronicle of the World Health Organization 23 (1969): 103–11. [Google Scholar]
36. Arhin‐Tenkorang D. and Conceição P., “Beyond Communicable Disease Control: Health in the Age of Globalization,” in Kaul I., Conceição P., Le Goulven K., and Mendoza R. U., eds., Providing Global Public Goods: Managing Globalization ( Oxford : Oxford University Press, 2003): 484–515, at 487. [Google Scholar]
37. World Health Organization , Declaration of A Ima‐Ata, adopted at the International Conference on Primary Health Care, Alma‐Ata, USSR, September 12, 1978.
38. Mann J., “Human Rights and AIDS: The Future of the Pandemic,” in Mann J.M., Gruskin S., Grodin M.A., and Annas G.J., eds., Health and Human Rights ( London : Routledge, 1999): 216–26. [Google Scholar]
39. For an overview of international human rights law, see Hannum H., “Human Rights,” in Schachter O. and Joyner C.C., eds., United Nations Legal Order ( Cambridge : Cambridge University Press, 1995): 319–48. [Google Scholar]
40. See generally Vincent R.J., Human Rights and International Relations ( Cambridge : Cambridge University Press, 1986). [Google Scholar]
41. See Gostin L.O. and Lazzarini Z., Human Rights and Public Health in the AIDS Pandemic ( Oxford : Oxford University Press, 1997). [Google Scholar]
42. On globalization and public health, see Lee K., ed., Health Impacts of Globalization: Toward Global Governance ( London : Palgrave, 2003); K. Lee, K. Buse, and S. Fustukian, eds., Health Policy in a Globalizing World (Cambridge: Cambridge University Press, 2002). [Google Scholar]
43. IHR, supra note 25, at Article 3; World Health Organization, supra note 26, at 3; Fidler, supra note 20, at 73–74.
44. World Health Organization , supra note 26, at 3 (listing dependence on country notification as a major constraint for surveillance and public health protection).
45. On global health governance, see Dodgson R., Lee K., and Drager N., Global Health Governance: A Conceptual Review (Key Issues in Global Health Governance Discussion Paper No. 1) ( London : World Health Organization and Centre on Global Change and Health, February 2002). [Google Scholar]
46. Loewenson R., Civil Society Influence on Global Health Policy (April 2003), at <http://www.tarsc.org/WHOCSI/pdf/WHOTARSC4.pdf> (last visited June 20, 2003); World Health Organization, Strategic Alliances—The Role of Civil Society in Health (2001). at <http://www.who.int/civilsociety/documents/alliances_en.pdf> (last visited June 20, 2003).
47. Horton R., “WHO: The Casualties and Compromises of Renewal,” The Lancet, 359 (2002): 1605–11. [DOI] [PubMed] [Google Scholar]
48. Constitution of the World Health Organization, July 22, 1946, in World Health Organization , Basic Documents, 40th ed. ( Geneva : World Health Organization, 1994): 1–18, at Article 71; Christopher Lanord, A Study of WHO'S Official Relations System with Nongovernmental Organizations (June 2002), at <http://www.who.int/civilsociety/documents/study.pdf> (last visited June 20, 2003); World Health Organization, Analysis: NGO Participation in WHO Governing Bodies, 1998–2002 (June 2002), at <http://www.who.int/civilsociety/documents/analysis.pdf> (last visited June 20, 2003). [Google Scholar]
49. The Global Fund to Fight AIDS, Tuberculosis, and Malaria, at <http://www.globalfundatm.org/news.html> (last visited June 20, 2003).
50. On global public goods for health generally, see Smith R., Beaglehole R., Woodward D., and Drager N., eds., Global Public Goods for Health: Health Economic and Public Health Perspectives ( Oxford : Oxford University Press, 2003). [Google Scholar]
51. Kaul I., Grunberg I., and Stern M.A., “Defining Global Public Goods,” in Kaul I., Grunberg I., and Stern M.A., eds., Global Public Goods: International Cooperation in the 21st Century ( Oxford : Oxford University Press, 1999): 2–19, at 3; D. Woodward and R.D. Smith, “Global Public Goods and Health: Concepts and Issues,” in R. Smith, R. Beaglehole, D. Woodward, and N. Drager, eds., Global Public Goods for Health: Health Economic and Public Health Perspectives (Oxford: Oxford University Press, 2003): 3–29, at 4–5. [Google Scholar]
52. Kaul, Grunberg, and Stern, supra note 50, at 10; Woodward and Smith, supra note 50, at 8.
53. Woodward and Smith, supra note 50, at 10–15.
54. Id. at 10–12, 14.
55. On public‐private partnerships in global public health, see Reich M., ed., Public‐Private Partnerships for Public Health ( Cambridge , MA : Harvard University Press, 2002). [Google Scholar]
56. World Health Organization , Global Defense Against the Infectious Disease Threat, (Kindhauser M.K., ed.) ( Geneva : World Health Organization, 2003), at 22. [Google Scholar]
57. For an example of such a PPP, see The Global Alliance for TB Drug Development, at <http://www.tballiance.org/> (last visited June 21, 2003).
58. World Health Organization , supra note 56, at 22.
59. World Health Assembly , Revision and Updating of the International Health Regulations, WHA48.7, May 12, 1995.
60. For an overview, see World Health Organization , supra note 26.
61. Id. at 7–8.
62. World Health Organization , The International Response to Epidemics and Applications of the International Health Regulations: Report of a WHO Informal Consultation, WHO/EMC/IHR/96.1, December 1114, 1995, at 10.
63. World Health Organization , supra note 26, at 3.
64. Id. at 7–8.
65. Id. at 7.
66. Id. at 3.
67. Leive D. M., International Regulatory Regimes, Vol. 1 ( Lexington , MA : Lexington Books, 1976): at 83–85. [Google Scholar]
68. World Health Organization , supra note 26, at 7–8.
69. Woodward and Smith, supra note 51, at 14.
70. Fidler, supra note 20, at 65–66.
71. World Health Organization , supra note 26, at 3.
72. Heymann D.L., “The Microbial Threat in Fragile Times: Balancing Known and Unknown Risks,” Bulletin of the World Health Organization 80 (2002): 179. [PMC free article] [PubMed] [Google Scholar]
73. World Health Organization , supra note 8, at 4.
74. World Health Assembly , Global Health Security: Epidemic Alert and Response, WHA54.14, May 21, 2001.
75. The Global Fund announced in January 2003 that it did not have sufficient funds to complete a third round of funding and urgently needed more than US$6 billion over the next two years. Global Fund to Fight AIDS, Tuberculosis, and Malaria, Press Release: Global Fund Awards $866 Million in Grants to Fight AIDS, TB and Malaria; United States Takes Chair of Global Fund Board; Tommy Thompson is Elected (January 31, 2003), at <http://www.globalfundatm.org/journalists/press%20releases/pr_030131b.html> (last visited June 21, 2003).
76. Narasimhan V. and Attaran A., “Roll Back Malaria? The Scarcity of International Aid for Malaria Control,” Malaria Journal, at <http://www.malariajournal.com/content/2/1/8> (last visited September 7, 2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
77. World Health Organization , supra note 8, at 1.
78. Pomfret J. and Goodman P. S., “Mysterious Illness Kills 2 in Beijing in Sign of Spread,” Washington Post, March 22, 2003, at A03 (reporting Chinese government efforts before early February 2003 to suppress media coverage about the outbreak in Guangdong Province). [Google Scholar]
79. See Pomfret J., “Outbreak Gave China's Hu an Opening; President Responded to Pressure Inside and Outside Country on SARS,” Washington Post, May 13, 2003, at A01; H. Hoenig, “Beijing Goes High Tech to Block SARS Messages,”New Zealand Herald (June 16, 2003), available at <http://www.nzherald.co.nz/storydisplay.cfm?thesection=news&thesubsection=&storyID=3507534&reportID=912595>. [Google Scholar]
80. ProMED, About ProMed‐mail, at <http://www.promedmail.org>.
81. ProMED‐mail, Pneumonia — China (Guangdong): RFI, February 10, 2003, Archive Number 20030210.0357.
82. Piller C., “In SARS Aftermath, WHO'S in Charge,” Los Angeles Times, July 13, 2003, at A1. [Google Scholar]
83. World Health Organization , supra note 8, at 4.
84. D. G. McNeil, Jr. and Altman L. K., “As SARS Outbreak Took Shape, Health Agency Took Fast Action,” New York Times, May 4, 2003, at 1. [Google Scholar]
85. World Health Organization , Acute Respiratory Syndrome in China (February 11, 2003), at <http://www.who.int/csr/don/2003_02_11/en/> (last visited June 10, 2003).
86. Pomfret and Goodman, supra note 78, at A03.
87. World Health Organization , Acute Respiratory Syndrome in Hong Kong Special Administrative Region of China/Viet Nam (March 12, 2003), at <http://who.int/csr/don/2003_03_12/en/> (last visited June 10, 2003).
88. World Health Organization , supra note 9.
89. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 2 (March 17, 2003), at <http://www.who.int/csr/don/2003_03_17/en/> (last visited June 10, 2003).
90. World Health Organization , Acute Respiratory Syndrome in China — Update 2 (February 14, 2003), at <http://www.who.int/csr/don/2003_02_14/en/> (last visited June 10, 2003).
91. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 10 (March 26, 2003), at <http://www.who.int/csr/don/2003_03_26/en/> (last visited June 10, 2003).
92. Pomfret J., “Underrporting, Secrecy Fuel SARS in Beijing, WHO Says,” Washington Post, April 17, 2003, at A16. [Google Scholar]
93. Jakes S., “Beijing Hoodwinks WHO Inspectors,” Time (April 18, 2003), available at <http://www.time.com/time/asia/news/claily/0,9754,444684,00.html>. [Google Scholar]
94. Pomfret J., “China Raises Disease's Death Toll; Under Pressure, Officials Admit Spread of Infection to Beijing,” Washington Post, March 27, 2003, at A16. [Google Scholar]
95. Pomfret J., “China Orders End to SARS Coverup; Officials Begin Belated Campaign Against Disease,” Washington Post, April 19, 2003, at A08. [Google Scholar]
96. Pomfret J., “SARS Coverup Spurs a Shake‐Up in Beijing,” Washington Post, April 21, 2003, at A01. [Google Scholar]
97. World Health Organization , Update 79 — Situation in China (June 12, 2003), at <http://www.who.int/csr/don/2003_06_12/en/> (last visited July 10, 2003).
98. Fidler D.P., SARS and International Law, American Society of International Law Insight; (April 2003), at <http://www.asil.org/insights/insigh101.htm> (last visited June 20, 2003). [Google Scholar]
99. Huang Y., Mortal Peril: Public Health in China and Its Security Implications (Health and Security Series Special Report No. 7) ( Washington , D.C. : Chemical and Biological Arms Control Institute, 2003): 65–77. [Google Scholar]
100. Fidler, supra note 20, at 66.
101. World Health Organization , supra note 62, at 10.
102. World Health Organization , supra note 8, at 8.
103. Pan P.P., “China Admits AIDS ‘Epidemic’; Disease May be Spreading Twice as Fast as Reported,” Washington Post, August 24, 2001, at A01. [Google Scholar]
104. UNAIDS , HIV/AIDS: China's Titanic Peril—2001 Update of the AIDS Situation and Needs Assessment Report ( Geneva : UNAIDS, June 2002): 7. [Google Scholar]
105. Id. at 70. On China's violation of freedom of speech, association, and assembly in connection with HIV/AIDS, see Human Rights Watch , Locked Doors: The Human Rights of People Living with HIV/AIDS in China ( Washington , D.C. : Human Rights Watch, 2003): 28–33. [Google Scholar]
106. Rosenthal E., “China's Top AIDS Activist Missing; Arrest Suspected,” New York Times, August 29, 2002, at A3; P. P. Pan, “China Detaining Prominent AIDS Activist,”Washington Post, September 7, 2002, at A14. [Google Scholar]
107. China Under Cover,” Washington Post, September 2, 2002, at A22. [Google Scholar]
108. Arguments about the direct connection between the quality of the public's health and the nature of a state's government have been around since at least the eighteenth century. Thomas Jefferson asserted, for example, “that sick populations were the result of sick political systems. … According to Jefferson, despotism produced disease, democracy liberated health.” Porter D., Health, Civilization, and the State: A History of Public Health from Ancient to Modern Times ( London : Routledge, 1999): 57. [Google Scholar]
109. See, e.g., “China's Chernobyl,” Washington Post, April 22, 2003, at A18; J.M. Goldgeier, “Will SARS Be the Chinese Chernobyl?,”Los Angeles Times, April 23, 2003, at 13; “China's Chernobyl?,”The Economist, April 26, 2003, at 9–10. [Google Scholar]
110. Zacher M. W., “Global Epidemiological Surveillance: International Cooperation to Monitor Infectious Diseases,” in Kaul I., Grunberg I., and Stern M.A., eds., Global Public Goods: International Cooperation in the 21st Century ( New York : Oxford University Press, 1999): 266–83. [Google Scholar]
111. See generally, Ting‐Lun Huang E., “The Modern Concept of Sovereignty, Statehood and Recognition: A Case Study of Taiwan,” New York International Law Review 16 (2003): 99–190. [Google Scholar]
112. Watts J., “China Takes Drastic Action Over SARS Threat,” The Lancet, 361 (2003): 1708–09, at 1709. [DOI] [PubMed] [Google Scholar]
113. World Health Assembly , Revision of the International Health Regulations, WHA56.28, May 28, 2003, at §4(1).
114. World Health Organization , supra note 87.
115. World Health Organization , supra note 9.
116. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 17 (April 2, 2003), at <http://www.who.int/csr/don/2003_04_02/en/> (last visited June 10, 2003).
117. Id. .
118. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 37 (April 23, 2003), at <http://www.who.int/csr/don/2003_04_23/en/> (last visited June 10, 2003).
119. Id. .
120. Id. .
121. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 50 (May 8, 2003), at <http://www.who.int/csr/don/2003_05_08/en/> (last visited June 10, 2003).
122. Id. .
123. Id. .
124. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 58 (May 17, 2003), at <http://www.who.int/csr/don/2003_05_17/en/> (last visited June 10, 2003).
125. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 61 (May 21, 2003), at <http://www.who.int/csr/don/2003_05_21/en/> (last visited June 10, 2003).
126. WHO has described the emergency travel advisory issued on March 15, 2003 as “rare,” World Health Organization, supra note 8, at 4, and “unprecedented,” World Health Organization, Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 27 (April 11, 2003), at <http://www.who.int/csr/don/2003_04_11/en/> (last visited June 10, 2003) [hereinafter World Health Organization, Update 27]. WHO reported that, prior to SARS, the Organization had never issued travel advice for specific geographical locations because of an outbreak of infectious diseases. World Health Organization, Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak — Update 19 (April 2, 2003), at <http://www.who.int/csr/don/2003_04_02/en/> (last visited June 10, 2003) [hereinafter World Health Organization, Update 19].
127. World Health Organization , Update 19, supra note 126. .
128. World Health Organization , Director‐General Says Food Import Bans are Inappropriate for Fighting Cholera, Press Release WHO/24, February 16, 1998.
129. World Health Organization , supra note 26, at 8–10.
130. Id. at 10 (emphasis added).
131. Id. at 9–10.
132. Id. .
133. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 18 (April 2, 2003), at <http://www.who.int/csr/don/2003_04_02/en/> (last visited June 10, 2003).
134. Brown D. L., “Virus Worry Fades in Toronto, but Concern Lingers; Residents Begin to Pick Up Their Old Routines; Officials Call WHO Travel Advisory Unnecessary,” Washington Post, April 24, 2003, at A20. [Google Scholar]
135. Piller, supra note 82, at A1.
136. Id. .
137. On the controversy over the Toronto travel advisory, see S. Frank, “Suddenly, All Smiles,”Time (Canadian Edition), May 12, 2003, available at 2003 WL 11985677.
138. World Health Assembly , supra note 113, at paragraph 4(2).
139. Id. .
140. National Intelligence Council , SARS: Down But Still a Threat (Intelligence Community Assessment 2003–09) ( Washington , D.C. : National Intelligence Council, 2003): 23. [Google Scholar]
141. World Health Organization , World Health Organization Announces New Public‐Private Initiative on Disease Surveillance, (Press Release) (May 22, 2003), at <http://www.who.int/mediacentre/releases/2003/prwha3/en/> (last visited May 22, 2003).
142. Id. .
143. Commenting on the PPP initiative, David L. Heymann, Executive Director of Communicable Diseases at WHO, observed that “[t]here have teen no resources for this in the past.” Quoted in V. Fuhrmans and G. Naik, “The WHO Wants Company Money to Battle SARS,”Wall Street Journal, May 22, 2003, at D3.
144. Id. .
145. World Health Organization , Update 27, supra note 126; R. Stein, “Mystery Illness Mortality Rate 4%, WHO Officials Say,”Washington Post, March 27, 2003, at A15.
146. The Director of the U.S. Centers for Disease Control and Prevention noted: “Speed of scientific discovery and speed of communication are hallmarks of the response to SARS and reflect amazing achievements in science, technology, and international collaboration.” J. Gerberding, “Faster … but Fast Enough? Responding to the Epidemic of Severe Acute Respiratory Syndrome,” New England Journal of Medicine, 348 (2003): 2030–31, at 2030. [DOI] [PubMed]
147. “SARS: Race to Patent Vims Renews Debate Over ‘Patents on Life,’”Medical Letter on the CDC & FDA, June 1, 2003, available at 2003 WL 8982543 (reporting on efforts of the CDC's patent strategy on the SARS virus to prevent others from monopolizing it through intellectual property rights).
148. See sources cited in note 3 supra..
149. National Intelligence Council , supra note 140, at 29.
150. World Health Organization , Update 83 — One Hundred Days into the Outbreak (June 18, 2003), at <http://www.who.int/csr/don/2003_06_18/en/> (last visited June 20, 2003).
151. “SARS: How Effective is the State and Local Response?”: Hearing Before the Permanent Subcommittee on Investigations of the U.S. Senate Governmental Affairs Committee, 108th Cong., at 10–24 (May 21, 2003) (testimony of J.L. Gerberding, A.S. Fauci, and M.T. Osterholm).
152. The General Accounting Office argued, for example, that “while the efforts of public health agencies and health care organizations to increase their preparedness for major public health threats such as influenza pandemics and bioterrorism have improved the nation's capacity to respond to SARS and other emerging infectious disease outbreaks, gaps in preparedness remain.” General Accounting Office, SARS Outbreak: Improvements to Public Health Capacity Are Needed for Responding to Bioterrorism and Emerging Infectious Diseases, GAO‐03–769T, May 7, 2003.
153. See, e.g., McBride S., “China and ASEAN Make Overtures to Calm Public; National Leaders Agree on Measures to Combat Illness, Protect Economies,” Asian Wall Street Journal, April 30, 2002, at A1. [Google Scholar]
154. See generally Gostin and Lazzarini, supra note 41.
155. WHO argues that “[a]ccess to essential drugs is part of the human right to health.” World Health Organization, Globalization, TRIPS and Access to Pharmaceuticals (WHO Policy Perspectives on Medicines No. 3, March 2001), at 5.
156. D.G. McNeil, Jr. , “Health Official Wield a Big Stick, Carefully, Against SARS,” New York Times, April 20, 2003, at A12; Fidler, supra note 98. [Google Scholar]
157. See, e.g., Annas G.J., “Bioterrorism, Public Health, and Civil Liberties,” New England Journal of Medicine, 346 (2002): 1337–42. [DOI] [PubMed] [Google Scholar]
158. For discussion, see Fidler, supra note 20, at 200–03.
159. Pottinger M., “The SARS Outbreak: In Some Nations SARS Appears to Have Peaked,” Wall Street Journal, April 29, 2003, at A2 (“Singapore adopted even stricter measures, imposing 10‐day home quarantines on thousands of people who might have come in contact with SARS patients, and threatening stiff penalties for people who violated the orders.”). [Google Scholar]
160. McNeil, supra note 156, at A12 (noting use of voluntary isolation and quarantine by Canadian health officials).
161. U.S. Centers for Disease Control and Prevention, Questions and Answers: Travel and Quarantine, at <http://www.cdc.gov/ncidod/sars/qa/travel.htm> (last visited June 21, 2003) (“CDC is requesting locating information from travelers who are on flights with people suspected of having SARS. CDC, with the help of state and local health authorities, is attempting to follow‐up with these travelers for 14 days to make sure no one develops symptoms consistent with SARS.”).
162. See Fidler, supra note 20, at 47–52.
163. With respect to China, “[b]oth WHO and the Chinese Ministry of Health regard the emergency response to SARS as an excellent opportunity to strengthen, throughout the mainland, systems for directing and responding to all emerging and epidemic‐prone infectious diseases.” World Health Organization, Update 77—WHO Officials to Visit China (June 10, 2003), at <http://www.who.int/csr/don/2003_06_10/en/> (last visited June 10, 2003).
164. Id. .
165. National Intelligence Council , supra note 140, at 31.
166. See criticism of Medecins Sans Frontieres that “[t]he only section of the [G8] Action Plan [on Health issued in June 2003] that shows determination is for SARS. Diseases that primarily affect poor people and occur in places of little consequence to the global economy are not treated with the same urgency.” Medecins Sans Frontieres, G8 Offers World an “Inaction Plan” on Health (June 3, 2003), at <http://www.accessmed-msf.org/prod/publications.asp?scntid=3620031159124&contenttype=PARA> (last visited June 21, 2003). The G8 Action Plan on Health can be found at <http://www.g7.utoronto.ca/summit/2003evian/health_en.html> (last visited June 21, 2003).
167. For an overview, see Fact Sheet: The President's Emergency Plan for AIDS Relief, at <http://www.whitehouse.gov/news/releases/2003/01/20030129-1.html> (last visited June 21, 2003). Congress passed legislation to implement this plan in May 2003. See United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003, Pub. L. No. 108–25.
168. United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003, supra note 167 at §202(d).
169. World Health Organization , Cumulative Number of Reported Probable Cases (August 7, 2003), at <http://www.who.int/csr/sars/country/2003_08_07/en/> (last visited September 7, 2003).
170. National Intelligence Council , supra note 140, at 24.
171. Fidler D. P., “The Globalization of Public Health: Emerging Infectious Diseases and International Relations,” Indiana Journal of Global Legal Studies 5 (1997): 11–51, at 33–34. [Google Scholar]
172. World Health Organization , SARS Outbreak Contained Worldwide: Threat Remains and More Research Needed, Says WHO (July 5, 2003), at <http://www.who.int/mediacentre/releases/2003/pr56/en/> (last visited September 7, 2003).
173. Severe Acute Respiratory Syndrome Threat (SARS): Hearing Before the Senate Comm. on Health, Education, Labor and Pensions, 108th Cong., at 15. (April 7, 2003) (testimony of David L. Heymann, Executive Director, Communicable Diseases, World Health Organization and and).

[b1] 1. See, e.g., Hunt P., The Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health: Report of the Special Rapporteur, UN Doc. E/CN.4/2003/58, February 13, 2003.

[b2] 2. See, e.g., Commission on Macroeconomics and Health , Macroeconomics and Health: Investing in Health for Economic Development ( Geneva : World Health Organization, 2001). [Google Scholar]

[b3] 3. See, e.g. Brower and Chalk P., The Global Threat of New and Reemerging Infectious Diseases: Reconciling U.S. National Security and Public Health Policy ( Santa Monica : RAND, 2003). [Google Scholar]

[b4] 4. World Health Assembly , Severe Acute Respiratory Syndrome (SARS), WHA56.29, May 28, 2003.

[b5] 5. See, e.g., Smolinski M. S., Hamburg M. A., and Lederberg J., eds., Microbial Threats to Health: Emergence, Detection, and Response ( Washington , D.C. : National Academy Press, 2003); World Health Organization, World Health Report 1996: Fighting Disease, Fostering Development (Geneva: World Health Organization, 1996); J. Lederberg, R. E. Shope, S. C. Oaks, eds., Emerging Infections: Microbial Threats to Health in the United States (Washington, D.C.: National Academy Press, 1992). [Google Scholar]

[b6] 6. For an overview of the HIV/AIDS pandemic, see UNAIDS , AIDS Epidemic Update: December 2002 ( Geneva : UNAIDS, 2002). [Google Scholar]

[b7] 7. See Gostin L. O., Public Health Law: Power, Duty, Restraint ( Berkeley : University of California Press, 2000): 25–59. [Google Scholar]

[b8] 8. World Health Organization , Severe Acute Respiratory Syndrome (SARS): Status of the Outbreak and Lessons for the Immediate Future ( Geneva : World Health Organization, 2003): 3. [Google Scholar]

[b9] 9. World Health Organization , Severe Acute Respiratory Syndrome (SARS) — Multi‐Country Outbreak (March 15, 2003), at <http://www.who.int/csr/don/2003_03_15/en/html> (last visited June 10, 2003).

[b10] 10. Harding C. and Lim C.L., “The Significance of Westphalia: An Archaeology of the International Legal Order,” in Harding C. and Lim C.L., eds., Renegotiating Westphalia: Essays and Commentary on the European and Conceptual Foundations of Modern International Law ( The Hague : M. Nijhoff Publishers, 1999): 1–23. [Google Scholar]

[b11] 11. Id. at 5–6.

[b12] 12. Scholte J. A., “The Globalization of World Politics,” in Baylis J. and Smith S., eds., The Globalization of World Politics: An Introduction to International Relations, 2d ed. ( Oxford : Oxford University Press, 2001): 12–32, at 20. [Google Scholar]

[b13] 13. Dunne T. and Schmidt B.C., “Realism,” in Baylis J. and Smith S., eds., The Globalization of World Politics: An Introduction to International Relations, 2d ed. ( Oxford : Oxford University Press, 2001):141–61, at 143. [Google Scholar]

[b14] 14. Scholte, supra note 12, at 20; I. Brownlie, Principles of Public International Law, 5^th ed. (Oxford: Oxford University Press, 1998): at 289.

[b15] 15. Jackson R.H., “The Evolution of International Society,” in Baylis J. and Smith S., eds., The Globalization of World Politics: An Introduction to International Relations, 2d ed. ( Oxford : Oxford University Press, 2001): 35–50: at 43; Brownlie, supra note 14, at 289, 293–94. [Google Scholar]

[b16] 16. Brownlie, supra note 14, at 289; The S. S. Lotus (France v. Turkey), P. C. I. J. Series A, No. 10 (1927).

[b17] 17. Bull H., The Anarchical Society: A Study of Order in World Politics ( Basingstoke : Macmillan, 1977): at 200–29. [Google Scholar]

[b18] 18. Id. at 101–26; 184–99.

[b19] 19. Fidler D.P., “The Return of the Standard of Civilization,” Chicago Journal of International Law, 2 (2001): 137–57; G. Gong, The “Standard of Civilization” in International Society (Oxford: Oxford University Press, 1984). [Google Scholar]

[b20] 20. On this history, see Fidler D. P., International Law and Infectious Diseases ( Oxford : Clarendon Press, 1999): at 21–57; N. Howard‐Jones, The Scientific Background of the International Sanitary Conferences 1851–1938 (Geneva: World Health Organization, 1975) [hereinafter Howard‐Jones, Scientific Background]; N. M. Goodman, International Health Organizations and Their Work, 2d ed. (London: Churchill Livingstone, 1971); N. Howard‐Jones, “The Origins of International Health Work,”British Medical Journal, May 6, 1950: 1032–37 [hereinafter Howard‐Jones, “International Health Work”]. [Google Scholar]

[b21] 21. This situation prompted Robert Koch to argue in 1894 that the negotiation of the international sanitary conventions on cholera was “quite superfluous” because what was needed was for every country “to seize cholera by the throat and stamp it out.” Howard‐Jones, Scientific Background, supra note 20, at 76 (quoting Robert Koch).

[b22] 22. Fidler, supra note 20, at 35.

[b23] 23. Id. at 28–35.

[b24] 24. Howard‐Jones, “International Health Work,” supra note 20, at 1035.

[b25] 25. World Health Organization , International Health Regulations, 3d. ann. ed. ( Geneva : World Health Organization, 1983) [hereinafter IHR]. [Google Scholar]

[b26] 26. World Health Organization , Global Crises — Global Solutions: Managing Public Health Emergencies of International Concern Through the Revised International Health Regulations ( Geneva : World Health Organization, 2002): at 1. [Google Scholar]

[b27] 27. Fidler D.P., “Emerging Trends in International Law Concerning Global Infectious Disease Control,” Emerging Infectious Diseases, 9 (2003): 285–90, at 285–86. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b28] 28. IHR, supra note 25.

[b29] 29. Id. at Articles 2–13.

[b30] 30. Id. at Articles 14–22.

[b31] 31. Id. at Article 23.

[b32] 32. Id. at Article 1.

[b33] 33. The first International Sanitary Conference in 1851 addressed maritime quarantine measures against plague, cholera, and yellow fever. Goodman, supra note 20, at 46.

[b34] 34. On such widespread violations, see Fidler, supra note 20, at 65–66.

[b35] 35. Delon P.J., The International Health Regulations: A Practical Guide ( Geneva : World Health Organization, 1975); E. Roelsgaard, “Health Regulations and International Travel,”Chronicle of the World Health Organization 28 (1974): 265–68; P. Dorolle, “Old Plagues in the Jet Age: International Aspects of Present and Future Control of Communicable Diseases,”Chronicle of the World Health Organization 23 (1969): 103–11. [Google Scholar]

[b36] 36. Arhin‐Tenkorang D. and Conceição P., “Beyond Communicable Disease Control: Health in the Age of Globalization,” in Kaul I., Conceição P., Le Goulven K., and Mendoza R. U., eds., Providing Global Public Goods: Managing Globalization ( Oxford : Oxford University Press, 2003): 484–515, at 487. [Google Scholar]

[b37] 37. World Health Organization , Declaration of A Ima‐Ata, adopted at the International Conference on Primary Health Care, Alma‐Ata, USSR, September 12, 1978.

[b38] 38. Mann J., “Human Rights and AIDS: The Future of the Pandemic,” in Mann J.M., Gruskin S., Grodin M.A., and Annas G.J., eds., Health and Human Rights ( London : Routledge, 1999): 216–26. [Google Scholar]

[b39] 39. For an overview of international human rights law, see Hannum H., “Human Rights,” in Schachter O. and Joyner C.C., eds., United Nations Legal Order ( Cambridge : Cambridge University Press, 1995): 319–48. [Google Scholar]

[b40] 40. See generally Vincent R.J., Human Rights and International Relations ( Cambridge : Cambridge University Press, 1986). [Google Scholar]

[b41] 41. See Gostin L.O. and Lazzarini Z., Human Rights and Public Health in the AIDS Pandemic ( Oxford : Oxford University Press, 1997). [Google Scholar]

[b42] 42. On globalization and public health, see Lee K., ed., Health Impacts of Globalization: Toward Global Governance ( London : Palgrave, 2003); K. Lee, K. Buse, and S. Fustukian, eds., Health Policy in a Globalizing World (Cambridge: Cambridge University Press, 2002). [Google Scholar]

[b43] 43. IHR, supra note 25, at Article 3; World Health Organization, supra note 26, at 3; Fidler, supra note 20, at 73–74.

[b44] 44. World Health Organization , supra note 26, at 3 (listing dependence on country notification as a major constraint for surveillance and public health protection).

[b45] 45. On global health governance, see Dodgson R., Lee K., and Drager N., Global Health Governance: A Conceptual Review (Key Issues in Global Health Governance Discussion Paper No. 1) ( London : World Health Organization and Centre on Global Change and Health, February 2002). [Google Scholar]

[b46] 46. Loewenson R., Civil Society Influence on Global Health Policy (April 2003), at <http://www.tarsc.org/WHOCSI/pdf/WHOTARSC4.pdf> (last visited June 20, 2003); World Health Organization, Strategic Alliances—The Role of Civil Society in Health (2001). at <http://www.who.int/civilsociety/documents/alliances_en.pdf> (last visited June 20, 2003).

[b47] 47. Horton R., “WHO: The Casualties and Compromises of Renewal,” The Lancet, 359 (2002): 1605–11. [DOI] [PubMed] [Google Scholar]

[b48] 48. Constitution of the World Health Organization, July 22, 1946, in World Health Organization , Basic Documents, 40th ed. ( Geneva : World Health Organization, 1994): 1–18, at Article 71; Christopher Lanord, A Study of WHO'S Official Relations System with Nongovernmental Organizations (June 2002), at <http://www.who.int/civilsociety/documents/study.pdf> (last visited June 20, 2003); World Health Organization, Analysis: NGO Participation in WHO Governing Bodies, 1998–2002 (June 2002), at <http://www.who.int/civilsociety/documents/analysis.pdf> (last visited June 20, 2003). [Google Scholar]

[b49] 49. The Global Fund to Fight AIDS, Tuberculosis, and Malaria, at <http://www.globalfundatm.org/news.html> (last visited June 20, 2003).

[b50] 50. On global public goods for health generally, see Smith R., Beaglehole R., Woodward D., and Drager N., eds., Global Public Goods for Health: Health Economic and Public Health Perspectives ( Oxford : Oxford University Press, 2003). [Google Scholar]

[b51] 51. Kaul I., Grunberg I., and Stern M.A., “Defining Global Public Goods,” in Kaul I., Grunberg I., and Stern M.A., eds., Global Public Goods: International Cooperation in the 21st Century ( Oxford : Oxford University Press, 1999): 2–19, at 3; D. Woodward and R.D. Smith, “Global Public Goods and Health: Concepts and Issues,” in R. Smith, R. Beaglehole, D. Woodward, and N. Drager, eds., Global Public Goods for Health: Health Economic and Public Health Perspectives (Oxford: Oxford University Press, 2003): 3–29, at 4–5. [Google Scholar]

[b52] 52. Kaul, Grunberg, and Stern, supra note 50, at 10; Woodward and Smith, supra note 50, at 8.

[b53] 53. Woodward and Smith, supra note 50, at 10–15.

[b54] 54. Id. at 10–12, 14.

[b55] 55. On public‐private partnerships in global public health, see Reich M., ed., Public‐Private Partnerships for Public Health ( Cambridge , MA : Harvard University Press, 2002). [Google Scholar]

[b56] 56. World Health Organization , Global Defense Against the Infectious Disease Threat, (Kindhauser M.K., ed.) ( Geneva : World Health Organization, 2003), at 22. [Google Scholar]

[b57] 57. For an example of such a PPP, see The Global Alliance for TB Drug Development, at <http://www.tballiance.org/> (last visited June 21, 2003).

[b58] 58. World Health Organization , supra note 56, at 22.

[b59] 59. World Health Assembly , Revision and Updating of the International Health Regulations, WHA48.7, May 12, 1995.

[b60] 60. For an overview, see World Health Organization , supra note 26.

[b61] 61. Id. at 7–8.

[b62] 62. World Health Organization , The International Response to Epidemics and Applications of the International Health Regulations: Report of a WHO Informal Consultation, WHO/EMC/IHR/96.1, December 1114, 1995, at 10.

[b63] 63. World Health Organization , supra note 26, at 3.

[b64] 64. Id. at 7–8.

[b65] 65. Id. at 7.

[b66] 66. Id. at 3.

[b67] 67. Leive D. M., International Regulatory Regimes, Vol. 1 ( Lexington , MA : Lexington Books, 1976): at 83–85. [Google Scholar]

[b68] 68. World Health Organization , supra note 26, at 7–8.

[b69] 69. Woodward and Smith, supra note 51, at 14.

[b70] 70. Fidler, supra note 20, at 65–66.

[b71] 71. World Health Organization , supra note 26, at 3.

[b72] 72. Heymann D.L., “The Microbial Threat in Fragile Times: Balancing Known and Unknown Risks,” Bulletin of the World Health Organization 80 (2002): 179. [PMC free article] [PubMed] [Google Scholar]

[b73] 73. World Health Organization , supra note 8, at 4.

[b74] 74. World Health Assembly , Global Health Security: Epidemic Alert and Response, WHA54.14, May 21, 2001.

[b75] 75. The Global Fund announced in January 2003 that it did not have sufficient funds to complete a third round of funding and urgently needed more than US$6 billion over the next two years. Global Fund to Fight AIDS, Tuberculosis, and Malaria, Press Release: Global Fund Awards $866 Million in Grants to Fight AIDS, TB and Malaria; United States Takes Chair of Global Fund Board; Tommy Thompson is Elected (January 31, 2003), at <http://www.globalfundatm.org/journalists/press%20releases/pr_030131b.html> (last visited June 21, 2003).

[b76] 76. Narasimhan V. and Attaran A., “Roll Back Malaria? The Scarcity of International Aid for Malaria Control,” Malaria Journal, at <http://www.malariajournal.com/content/2/1/8> (last visited September 7, 2003). [DOI] [PMC free article] [PubMed] [Google Scholar]

[b77] 77. World Health Organization , supra note 8, at 1.

[b78] 78. Pomfret J. and Goodman P. S., “Mysterious Illness Kills 2 in Beijing in Sign of Spread,” Washington Post, March 22, 2003, at A03 (reporting Chinese government efforts before early February 2003 to suppress media coverage about the outbreak in Guangdong Province). [Google Scholar]

[b79] 79. See Pomfret J., “Outbreak Gave China's Hu an Opening; President Responded to Pressure Inside and Outside Country on SARS,” Washington Post, May 13, 2003, at A01; H. Hoenig, “Beijing Goes High Tech to Block SARS Messages,”New Zealand Herald (June 16, 2003), available at <http://www.nzherald.co.nz/storydisplay.cfm?thesection=news&thesubsection=&storyID=3507534&reportID=912595>. [Google Scholar]

[b80] 80. ProMED, About ProMed‐mail, at <http://www.promedmail.org>.

[b81] 81. ProMED‐mail, Pneumonia — China (Guangdong): RFI, February 10, 2003, Archive Number 20030210.0357.

[b82] 82. Piller C., “In SARS Aftermath, WHO'S in Charge,” Los Angeles Times, July 13, 2003, at A1. [Google Scholar]

[b83] 83. World Health Organization , supra note 8, at 4.

[b84] 84. D. G. McNeil, Jr. and Altman L. K., “As SARS Outbreak Took Shape, Health Agency Took Fast Action,” New York Times, May 4, 2003, at 1. [Google Scholar]

[b85] 85. World Health Organization , Acute Respiratory Syndrome in China (February 11, 2003), at <http://www.who.int/csr/don/2003_02_11/en/> (last visited June 10, 2003).

[b86] 86. Pomfret and Goodman, supra note 78, at A03.

[b87] 87. World Health Organization , Acute Respiratory Syndrome in Hong Kong Special Administrative Region of China/Viet Nam (March 12, 2003), at <http://who.int/csr/don/2003_03_12/en/> (last visited June 10, 2003).

[b88] 88. World Health Organization , supra note 9.

[b89] 89. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 2 (March 17, 2003), at <http://www.who.int/csr/don/2003_03_17/en/> (last visited June 10, 2003).

[b90] 90. World Health Organization , Acute Respiratory Syndrome in China — Update 2 (February 14, 2003), at <http://www.who.int/csr/don/2003_02_14/en/> (last visited June 10, 2003).

[b91] 91. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 10 (March 26, 2003), at <http://www.who.int/csr/don/2003_03_26/en/> (last visited June 10, 2003).

[b92] 92. Pomfret J., “Underrporting, Secrecy Fuel SARS in Beijing, WHO Says,” Washington Post, April 17, 2003, at A16. [Google Scholar]

[b93] 93. Jakes S., “Beijing Hoodwinks WHO Inspectors,” Time (April 18, 2003), available at <http://www.time.com/time/asia/news/claily/0,9754,444684,00.html>. [Google Scholar]

[b94] 94. Pomfret J., “China Raises Disease's Death Toll; Under Pressure, Officials Admit Spread of Infection to Beijing,” Washington Post, March 27, 2003, at A16. [Google Scholar]

[b95] 95. Pomfret J., “China Orders End to SARS Coverup; Officials Begin Belated Campaign Against Disease,” Washington Post, April 19, 2003, at A08. [Google Scholar]

[b96] 96. Pomfret J., “SARS Coverup Spurs a Shake‐Up in Beijing,” Washington Post, April 21, 2003, at A01. [Google Scholar]

[b97] 97. World Health Organization , Update 79 — Situation in China (June 12, 2003), at <http://www.who.int/csr/don/2003_06_12/en/> (last visited July 10, 2003).

[b98] 98. Fidler D.P., SARS and International Law, American Society of International Law Insight; (April 2003), at <http://www.asil.org/insights/insigh101.htm> (last visited June 20, 2003). [Google Scholar]

[b99] 99. Huang Y., Mortal Peril: Public Health in China and Its Security Implications (Health and Security Series Special Report No. 7) ( Washington , D.C. : Chemical and Biological Arms Control Institute, 2003): 65–77. [Google Scholar]

[b100] 100. Fidler, supra note 20, at 66.

[b101] 101. World Health Organization , supra note 62, at 10.

[b102] 102. World Health Organization , supra note 8, at 8.

[b103] 103. Pan P.P., “China Admits AIDS ‘Epidemic’; Disease May be Spreading Twice as Fast as Reported,” Washington Post, August 24, 2001, at A01. [Google Scholar]

[b104] 104. UNAIDS , HIV/AIDS: China's Titanic Peril—2001 Update of the AIDS Situation and Needs Assessment Report ( Geneva : UNAIDS, June 2002): 7. [Google Scholar]

[b105] 105. Id. at 70. On China's violation of freedom of speech, association, and assembly in connection with HIV/AIDS, see Human Rights Watch , Locked Doors: The Human Rights of People Living with HIV/AIDS in China ( Washington , D.C. : Human Rights Watch, 2003): 28–33. [Google Scholar]

[b106] 106. Rosenthal E., “China's Top AIDS Activist Missing; Arrest Suspected,” New York Times, August 29, 2002, at A3; P. P. Pan, “China Detaining Prominent AIDS Activist,”Washington Post, September 7, 2002, at A14. [Google Scholar]

[b107] 107. China Under Cover,” Washington Post, September 2, 2002, at A22. [Google Scholar]

[b108] 108. Arguments about the direct connection between the quality of the public's health and the nature of a state's government have been around since at least the eighteenth century. Thomas Jefferson asserted, for example, “that sick populations were the result of sick political systems. … According to Jefferson, despotism produced disease, democracy liberated health.” Porter D., Health, Civilization, and the State: A History of Public Health from Ancient to Modern Times ( London : Routledge, 1999): 57. [Google Scholar]

[b109] 109. See, e.g., “China's Chernobyl,” Washington Post, April 22, 2003, at A18; J.M. Goldgeier, “Will SARS Be the Chinese Chernobyl?,”Los Angeles Times, April 23, 2003, at 13; “China's Chernobyl?,”The Economist, April 26, 2003, at 9–10. [Google Scholar]

[b110] 110. Zacher M. W., “Global Epidemiological Surveillance: International Cooperation to Monitor Infectious Diseases,” in Kaul I., Grunberg I., and Stern M.A., eds., Global Public Goods: International Cooperation in the 21st Century ( New York : Oxford University Press, 1999): 266–83. [Google Scholar]

[b111] 111. See generally, Ting‐Lun Huang E., “The Modern Concept of Sovereignty, Statehood and Recognition: A Case Study of Taiwan,” New York International Law Review 16 (2003): 99–190. [Google Scholar]

[b112] 112. Watts J., “China Takes Drastic Action Over SARS Threat,” The Lancet, 361 (2003): 1708–09, at 1709. [DOI] [PubMed] [Google Scholar]

[b113] 113. World Health Assembly , Revision of the International Health Regulations, WHA56.28, May 28, 2003, at §4(1).

[b114] 114. World Health Organization , supra note 87.

[b115] 115. World Health Organization , supra note 9.

[b116] 116. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 17 (April 2, 2003), at <http://www.who.int/csr/don/2003_04_02/en/> (last visited June 10, 2003).

[b117] 117. Id. .

[b118] 118. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 37 (April 23, 2003), at <http://www.who.int/csr/don/2003_04_23/en/> (last visited June 10, 2003).

[b119] 119. Id. .

[b120] 120. Id. .

[b121] 121. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 50 (May 8, 2003), at <http://www.who.int/csr/don/2003_05_08/en/> (last visited June 10, 2003).

[b122] 122. Id. .

[b123] 123. Id. .

[b124] 124. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 58 (May 17, 2003), at <http://www.who.int/csr/don/2003_05_17/en/> (last visited June 10, 2003).

[b125] 125. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 61 (May 21, 2003), at <http://www.who.int/csr/don/2003_05_21/en/> (last visited June 10, 2003).

[b126] 126. WHO has described the emergency travel advisory issued on March 15, 2003 as “rare,” World Health Organization, supra note 8, at 4, and “unprecedented,” World Health Organization, Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 27 (April 11, 2003), at <http://www.who.int/csr/don/2003_04_11/en/> (last visited June 10, 2003) [hereinafter World Health Organization, Update 27]. WHO reported that, prior to SARS, the Organization had never issued travel advice for specific geographical locations because of an outbreak of infectious diseases. World Health Organization, Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak — Update 19 (April 2, 2003), at <http://www.who.int/csr/don/2003_04_02/en/> (last visited June 10, 2003) [hereinafter World Health Organization, Update 19].

[b127] 127. World Health Organization , Update 19, supra note 126. .

[b128] 128. World Health Organization , Director‐General Says Food Import Bans are Inappropriate for Fighting Cholera, Press Release WHO/24, February 16, 1998.

[b129] 129. World Health Organization , supra note 26, at 8–10.

[b130] 130. Id. at 10 (emphasis added).

[b131] 131. Id. at 9–10.

[b132] 132. Id. .

[b133] 133. World Health Organization , Severe Acute Respiratory Syndrome (SARS) Multi‐Country Outbreak—Update 18 (April 2, 2003), at <http://www.who.int/csr/don/2003_04_02/en/> (last visited June 10, 2003).

[b134] 134. Brown D. L., “Virus Worry Fades in Toronto, but Concern Lingers; Residents Begin to Pick Up Their Old Routines; Officials Call WHO Travel Advisory Unnecessary,” Washington Post, April 24, 2003, at A20. [Google Scholar]

[b135] 135. Piller, supra note 82, at A1.

[b136] 136. Id. .

[b137] 137. On the controversy over the Toronto travel advisory, see S. Frank, “Suddenly, All Smiles,”Time (Canadian Edition), May 12, 2003, available at 2003 WL 11985677.

[b138] 138. World Health Assembly , supra note 113, at paragraph 4(2).

[b139] 139. Id. .

[b140] 140. National Intelligence Council , SARS: Down But Still a Threat (Intelligence Community Assessment 2003–09) ( Washington , D.C. : National Intelligence Council, 2003): 23. [Google Scholar]

[b141] 141. World Health Organization , World Health Organization Announces New Public‐Private Initiative on Disease Surveillance, (Press Release) (May 22, 2003), at <http://www.who.int/mediacentre/releases/2003/prwha3/en/> (last visited May 22, 2003).

[b142] 142. Id. .

[b143] 143. Commenting on the PPP initiative, David L. Heymann, Executive Director of Communicable Diseases at WHO, observed that “[t]here have teen no resources for this in the past.” Quoted in V. Fuhrmans and G. Naik, “The WHO Wants Company Money to Battle SARS,”Wall Street Journal, May 22, 2003, at D3.

[b144] 144. Id. .

[b145] 145. World Health Organization , Update 27, supra note 126; R. Stein, “Mystery Illness Mortality Rate 4%, WHO Officials Say,”Washington Post, March 27, 2003, at A15.

[b146] 146. The Director of the U.S. Centers for Disease Control and Prevention noted: “Speed of scientific discovery and speed of communication are hallmarks of the response to SARS and reflect amazing achievements in science, technology, and international collaboration.” J. Gerberding, “Faster … but Fast Enough? Responding to the Epidemic of Severe Acute Respiratory Syndrome,” New England Journal of Medicine, 348 (2003): 2030–31, at 2030. [DOI] [PubMed]

[b147] 147. “SARS: Race to Patent Vims Renews Debate Over ‘Patents on Life,’”Medical Letter on the CDC & FDA, June 1, 2003, available at 2003 WL 8982543 (reporting on efforts of the CDC's patent strategy on the SARS virus to prevent others from monopolizing it through intellectual property rights).

[b148] 148. See sources cited in note 3 supra..

[b149] 149. National Intelligence Council , supra note 140, at 29.

[b150] 150. World Health Organization , Update 83 — One Hundred Days into the Outbreak (June 18, 2003), at <http://www.who.int/csr/don/2003_06_18/en/> (last visited June 20, 2003).

[b151] 151. “SARS: How Effective is the State and Local Response?”: Hearing Before the Permanent Subcommittee on Investigations of the U.S. Senate Governmental Affairs Committee, 108th Cong., at 10–24 (May 21, 2003) (testimony of J.L. Gerberding, A.S. Fauci, and M.T. Osterholm).

[b152] 152. The General Accounting Office argued, for example, that “while the efforts of public health agencies and health care organizations to increase their preparedness for major public health threats such as influenza pandemics and bioterrorism have improved the nation's capacity to respond to SARS and other emerging infectious disease outbreaks, gaps in preparedness remain.” General Accounting Office, SARS Outbreak: Improvements to Public Health Capacity Are Needed for Responding to Bioterrorism and Emerging Infectious Diseases, GAO‐03–769T, May 7, 2003.

[b153] 153. See, e.g., McBride S., “China and ASEAN Make Overtures to Calm Public; National Leaders Agree on Measures to Combat Illness, Protect Economies,” Asian Wall Street Journal, April 30, 2002, at A1. [Google Scholar]

[b154] 154. See generally Gostin and Lazzarini, supra note 41.

[b155] 155. WHO argues that “[a]ccess to essential drugs is part of the human right to health.” World Health Organization, Globalization, TRIPS and Access to Pharmaceuticals (WHO Policy Perspectives on Medicines No. 3, March 2001), at 5.

[b156] 156. D.G. McNeil, Jr. , “Health Official Wield a Big Stick, Carefully, Against SARS,” New York Times, April 20, 2003, at A12; Fidler, supra note 98. [Google Scholar]

[b157] 157. See, e.g., Annas G.J., “Bioterrorism, Public Health, and Civil Liberties,” New England Journal of Medicine, 346 (2002): 1337–42. [DOI] [PubMed] [Google Scholar]

[b158] 158. For discussion, see Fidler, supra note 20, at 200–03.

[b159] 159. Pottinger M., “The SARS Outbreak: In Some Nations SARS Appears to Have Peaked,” Wall Street Journal, April 29, 2003, at A2 (“Singapore adopted even stricter measures, imposing 10‐day home quarantines on thousands of people who might have come in contact with SARS patients, and threatening stiff penalties for people who violated the orders.”). [Google Scholar]

[b160] 160. McNeil, supra note 156, at A12 (noting use of voluntary isolation and quarantine by Canadian health officials).

[b161] 161. U.S. Centers for Disease Control and Prevention, Questions and Answers: Travel and Quarantine, at <http://www.cdc.gov/ncidod/sars/qa/travel.htm> (last visited June 21, 2003) (“CDC is requesting locating information from travelers who are on flights with people suspected of having SARS. CDC, with the help of state and local health authorities, is attempting to follow‐up with these travelers for 14 days to make sure no one develops symptoms consistent with SARS.”).

[b162] 162. See Fidler, supra note 20, at 47–52.

[b163] 163. With respect to China, “[b]oth WHO and the Chinese Ministry of Health regard the emergency response to SARS as an excellent opportunity to strengthen, throughout the mainland, systems for directing and responding to all emerging and epidemic‐prone infectious diseases.” World Health Organization, Update 77—WHO Officials to Visit China (June 10, 2003), at <http://www.who.int/csr/don/2003_06_10/en/> (last visited June 10, 2003).

[b164] 164. Id. .

[b165] 165. National Intelligence Council , supra note 140, at 31.

[b166] 166. See criticism of Medecins Sans Frontieres that “[t]he only section of the [G8] Action Plan [on Health issued in June 2003] that shows determination is for SARS. Diseases that primarily affect poor people and occur in places of little consequence to the global economy are not treated with the same urgency.” Medecins Sans Frontieres, G8 Offers World an “Inaction Plan” on Health (June 3, 2003), at <http://www.accessmed-msf.org/prod/publications.asp?scntid=3620031159124&contenttype=PARA> (last visited June 21, 2003). The G8 Action Plan on Health can be found at <http://www.g7.utoronto.ca/summit/2003evian/health_en.html> (last visited June 21, 2003).

[b167] 167. For an overview, see Fact Sheet: The President's Emergency Plan for AIDS Relief, at <http://www.whitehouse.gov/news/releases/2003/01/20030129-1.html> (last visited June 21, 2003). Congress passed legislation to implement this plan in May 2003. See United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003, Pub. L. No. 108–25.

[b168] 168. United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003, supra note 167 at §202(d).

[b169] 169. World Health Organization , Cumulative Number of Reported Probable Cases (August 7, 2003), at <http://www.who.int/csr/sars/country/2003_08_07/en/> (last visited September 7, 2003).

[b170] 170. National Intelligence Council , supra note 140, at 24.

[b171] 171. Fidler D. P., “The Globalization of Public Health: Emerging Infectious Diseases and International Relations,” Indiana Journal of Global Legal Studies 5 (1997): 11–51, at 33–34. [Google Scholar]

[b172] 172. World Health Organization , SARS Outbreak Contained Worldwide: Threat Remains and More Research Needed, Says WHO (July 5, 2003), at <http://www.who.int/mediacentre/releases/2003/pr56/en/> (last visited September 7, 2003).

[b173] 173. Severe Acute Respiratory Syndrome Threat (SARS): Hearing Before the Senate Comm. on Health, Education, Labor and Pensions, 108th Cong., at 15. (April 7, 2003) (testimony of David L. Heymann, Executive Director, Communicable Diseases, World Health Organization and and).

PERMALINK

SARS: Political Pathology of the First Post‐Westphalian Pathogen

David P Fidler

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

SARS: Political Pathology of the First Post‐Westphalian Pathogen

David P Fidler

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases